Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1

Surgery

Volumn 122, Issue 6, 1997, Pages 1012-1020

  Mutch, Matthew G ^a,b   Frisella, Margaret M ^a,b   DeBenedetti, Mary K ^a,b   Doherry, Gerard M ^a,b   Norton, Jeffrey A ^a,b   Wells Jr , Samuel A ^a,b   Lairmore, Terry C ^a,b  

^a School of Medicine ^*

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PANCREAS POLYPEPTIDE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; RADIOGRAPHY; SCINTISCANNING;

EID: 0031443575     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90203-8     Document Type: Article

References (17)

1. Legaspi A, Brennan MF. Management of islet cell carcinoma. Surgery 1988;104:1018-23.
2. Sheppard BC, Norton JA, Doppman JL, Maton PN, Gardner JD, Jensen RT. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery s01989;106:1108-18.
3. Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani SA, Gagel RF, et al. Nonfunctioning islet cell carcinoma of the pancreas. Surgery 1993;114:1175-82.
4. Polak JM, Adrian TE, Bryant MG, Bloom SR, Heitz PH, Pearse AGE. Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet 1976;1:328-30.
5. Larsson LI, Schwartz T, Lundqvist G, et al. Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Am J Pathol 1976;85:675-82.
6. Friesen SR, Kimmel JR, Tomita T. Pancreatic polypeptide as screening marker for pancreatic polypeptide apudomas in multiple endocrinopathies. Am J Surg 1980;139:61-72.
7. Friesen SR, Tomita T, Kimmel JR. Pancreatic polypeptide update: its roles in detection of the trait for multiple endocrine adenopathy syndrome, type I, and pancreatic polypeptide-secreting tumors. Surgery 1983;94:1028-37.
8. Kimmel JR, Pollock HG, Hazelwood RL. Isolation and characterization of chicken insulin. Endocrinology 1968;83:1323-30.
9. Kimmel JR, Hayden LJ, Pollock HG. Isolation and characterization of a new pancreatic polypeptide hormone. J Biol Chem 1975;250:9369-76.
10. Lonovics J, Devitt P, Watson LC, Rayford PL, Thompson JC. Pancreatic polypeptide: a review. Arch Surg 1981;116:1256-64.
11. Orci L, Malaisse-Lagae F, Baetens D, et al. Pancreatic-polypeptide-rich regions in human pancreas. Lancet 1978;2:1200-1.
12. Floyd JCJ, Fajans SS, Pek S, Chance RE. A newly recognized pancreatic polypeptide: plasma levels in health and disease. Recent Prog Horm Res 1977;33:519-30.
13. Langstein HN, Norton JA, Victor Chiang H-C, et al. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors. Surgery 1990;108:1109-16.
14. Wilkinson S, Teh BT, Davey KR, McArdle JP, Young M, Shepard JJ. Cause of death in multiple endocrine neoplasia type 1. Arch Surg 1993;128:683-90.
15. Majewski JT, Wilson SD. The MEA-I syndrome: an all or none phenomemon? Surgery 1979;86:475-84.
16. Frucht H, Howard JM, Slaff JI, et al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. Ann Intern Med 1989;111:713-22.
17. Frucht H, Howard JM, Stark HA, et al. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome. Am J Med 1989;87:528-36.